| Authors: |
Hauser SL; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. Electronic address: stephen.hauser@ucsf.edu., Freedman MS; University of Ottawa, Department of Medicine (Neurology), and the Ottawa Hospital Research Institute, Ontario, Canada. Electronic address: mfreedman@toh.ca., Nakahara J; Department of Neurology, Keio University School of Medicine, Tokyo, Japan. Electronic address: nakahara.a6@keio.jp., Paling D; Department of Clinical Neurology, Royal Hallamshire Hospital, Sheffield, UK. Electronic address: david.paling@nhs.net., de Seze J; University Hospital of Strasbourg, Strasbourg, France. Electronic address: jerome.de.seze@chru-strasbourg.fr., Li J; Novartis Pharma AG, Basel, Switzerland. Electronic address: jun-1.li@novartis.com., Abeyewickreme A; Novartis Pharmaceuticals UK Ltd, London, UK. Electronic address: anil.abeyewickreme@novartis.com., Wu M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. Electronic address: min.wu@novartis.com., Sullivan R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. Electronic address: roseanne.sullivan@novartis.com., Pardo G; Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. Electronic address: gabriel-pardo@omrf.org., Montalban X; Department of Neurology-Neuroimmunology and Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain. Electronic address: xavier.montalban@cem-cat.org., Wiendl H; Klinik für Neurologie und Neurophysiologie, Universitätsklinikum Freiburg, Freiburg, Germany. Electronic address: heinz.wiendl@uniklinik-freiburg.de. |
